The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%. Also read: UnitedHealthcare head Brian Thompson's killing shines light on health-insurance denial rates.

These include, but are not limited to, the big three drug middlemen known as pharmacy benefit managers (PBMs). According to ...

Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...